IP Library Granted Patent US 7,543,589
Granted Patent B2
US 7,543,589 · App. 11/675,195 · Granted Jun 9, 2009

Method for ablating cardiac tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,543,589
App. No.
11/675,195
Granted
Jun 9, 2009
Kind
B2
Abstract

A method and apparatus for transmural ablation using an instrument containing two electrodes or cryogenic probes. A clamping force is exerted on the two electrodes or probes such that the tissue of the hollow organ is clamped therebetween. Bipolar RF energy is then applied between the two electrodes, or the probes are cryogenically cooled, thus ablating the tissue therebetween. The method provides for ablating cardiac tissue of a patient utilizing a sub-xyphoid approach and identifying cardiac tissue prior to ablation.

Claims (34)

1. A method for creating an electrically isolated line of ablated tissue in cardiac tissue comprising:

a) clamping cardiac tissue between a pair of jaws each of which carries a conductive member;

b) passing sufficient bi-polar electrical current between the conductive members through the cardiac tissue to form a line of ablation in the cardiac tissue;

c) gauging the completeness of tissue ablation; and

d) indicating to the user when tissue ablation is complete.

2. The method of claim 1 in which gauging the completeness includes monitoring impedance.

3. The method of claim 2 in which gauging the completeness includes monitoring the change in impedance.

4. The method of claim 1 in which gauging the completeness includes monitoring current.

5. The method of claim 1 in which gauging the completeness includes monitoring voltage.

6. The method of claim 1 in which gauging the completeness includes monitoring tissue temperature.

7. The method of claim 1 further including stopping the electrical current when it is gauged that the ablation is transmural.

8. The method of claim 1 in which the completeness of tissue ablation is gauged simultaneously with passing electrical current through the cardiac tissue to form the line of ablation in the tissue.

9. The method of claim 1 wherein the clamping further comprises bringing opposed walls of cardiac tissue together and then passing current through both walls simultaneously.

10. The method of claim 1 in which the indication to the user that tissue ablation is complete is a visual signal.

11. The method of claim 10 wherein the visual signal is a light.

12. The method of claim 1 in which the indication to the user that tissue ablation is complete is an audible signal.

13. A method for creating an electrically isolated line of ablated tissue in cardiac tissue comprising:

a) clamping cardiac tissue between a pair of jaws each of which carries a conductive member;

b) passing sufficient bi-polar electrical current between the conductive members through the cardiac tissue to form a line of ablation in the cardiac tissue;

c) gauging the completeness of tissue ablation by monitoring one or more of tissue temperature and at least one electrical characteristic relating to ablation; and

d) indicating to the user when tissue ablation is complete.

14. The method of claim 13 wherein the clamping further comprises bringing opposed walls of cardiac tissue together and then passing current through both walls simultaneously.

15. The method of claim 13 in which the indication to the user that tissue ablation is complete is a visual signal.

16. The method of claim 15 wherein the visual signal is a light.

17. The method of claim 13 in which the indication to the user that tissue ablation is complete is an audible signal.

18. A method for creating an electrically isolated line of ablated tissue in cardiac tissue comprising:

a) clamping cardiac tissue between a pair of jaws each of which carries a conductive member;

b) passing sufficient bi-polar electrical current between the conductive members through the cardiac tissue to form a line of ablation in the cardiac tissue;

c) gauging the completeness of tissue ablation by monitoring transmission of an electrical signal across the line of ablation; and

d) indicating to the user when tissue ablation is complete.

19. The method of claim 18 in which gauging the completeness includes generating an electrical signal in the tissue on one side of the line of ablation and sensing whether it is transmitted across the line of ablation.

20. The method of claim 18 in which the indication to the user that tissue ablation is complete is a visual signal.

21. The method of claim 20 wherein the visual signal is a light.

22. The method of claim 18 in which the indication to the user that tissue ablation is complete is an audible signal.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC; SENTREHEART LLC
Reel/Frame 066256/0797 →
SECURITY INTEREST Recorded Dec 18, 2018
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 047951/0496 →
SECOND AMENDED AND RESTATED JOINT INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 25, 2016
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 038520/0062 →
SECURITY INTEREST Recorded May 2, 2014
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 032812/0032 →